Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "microbial removal via surfactant action" refers to the process by which surfactants—both synthetic and microbial (biosurfactants)—aid in the elimination of microorganisms from surfaces and environments. Surfactants possess amphiphilic structures with hydrophilic and hydrophobic domains, allowing them to reduce surface and interfacial tension, lift and solubilize microbial cells, emulsify dirt or organic matter, and disrupt microbial membranes. Microbial-derived surfactants (biosurfactants), such as rhamnolipids and surfactin, are increasingly valued for their environmental compatibility and multifunctional properties, including antimicrobial, anti-adhesive, and cleansing actions. This mechanism plays a key role in sanitation, infection control, environmental cleanup, and certain aspects of innate immunity, but does not represent a single molecular drug target as typically defined in pharmacology.
Physical disruption of microbial membranes, Micelle formation and emulsification of contaminants, Reduction of surface tension to facilitate detachment of microbes, Enhanced solubilization and dispersion of hydrophobic particles
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial removal via surfactant action.